ClinicalTrials.Veeva

Menu
M

Midland Florida Clinical Research Center, LLC | DeLand, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Enobosarm
Lenacapavir
Emtricitabine
TAF
Tenofovir Alafenamide
Bictegravir
GTx-024
GS-4182
GS-1720
Elagolix

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

11 of 30 total trials

A Clinical Investigation Evaluating Wound Closure with OptiPulse™ Versus SOC in the Treatment of Non-Healing DFU's

The purpose of this clinical investigation is to assess the safety and performance of Compedica's OptiPulse™ and to collect subject outcome data on t...

Enrolling
Diabetic Foot Ulcer
Device: OptiPulse™
Device: Standard of Care offloading device

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Active, not recruiting
Crohn's Disease
Drug: Mirikizumab

The goal of this study is to test the effectiveness, safety, and tolerability of the combination of broadly neutralizing antibodies (bNAbs) (teropavi...

Active, not recruiting
HIV Infections
Drug: Lenacapavir Tablet
Drug: Zinlirvimab

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Active, not recruiting
Human Immuno-deficiency Virus (HIV) Disease
Drug: Placebo for Budigalimab
Drug: Budigalimab

This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.

Enrolling
Osteomyelitis
Diabetic Foot Osteomyelitis
Biological: Phage Therapy
Other: Placebo

The goal of this clinical study is to learn more about the experimental drugs GS-1720 (an oral, long-acting integrase strand transfer inhibitor (INST...

Enrolling
HIV-1-infection
Drug: GS-4182
Drug: Bictegravir/emtricitabine/tenofovir alafenamide

The goal of this clinical study is to learn more about the experimental drugs GS-1720 and GS-4182; to compare the combination of GS-1720 and GS-4182...

Active, not recruiting
HIV-1-Infection
Drug: Placebo to Match BVY
Drug: Placebo to Match GS1720/GS-4182 FDC

This is a randomized, active-controlled, open-label study to assess the safety, tolerability and efficacy of Afabicin in the treatment of participant...

Active, not recruiting
Bone or Joint Infection
Drug: Afabicin
Drug: Standard of Care

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC) plus lenacapavir (LEN), versus...

Active, not recruiting
HIV-1-infection
Drug: Stable Baseline Regimen
Drug: Bictegravir

The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207) administered as an add-on to a failing re...

Active, not recruiting
HIV-1-infection
Drug: Optimized Background Regimen (OBR)
Drug: Oral Lenacapavir Placebo

Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or a...

Enrolling
HSV Infection
Drug: Investigator's choice
Drug: Pritelivir

Trial sponsors

Gilead Sciences logo
AbbVie logo
G
Pfizer logo
A
A
A
BeiGene logo
Bristol-Myers Squibb (BMS) logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems